The Bhumjaithai Party marked its 16th anniversary on Sunday by unveiling a new, all-blue logo, which its leader Anutin Charnvirakul said represented unity, loyalty and the party’s commitment to ...

SAN FRANCISCO (KGO) -- The big blue bird logo from the Twitter San Francisco headquarters is up for auction. This logo is about 12 feet tall, nine feet wide, and weighs in at roughly 560 pounds.

Beautiful Layout, Brilliant Design Posted: March 21, 2025 | Last updated: March 21, 2025 Smart layout, stylish finishes, and a space that just feels right—welcome to the Blue Jay by Franklin Homes.

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous challenges plaguing the company resulted in the dilution of the stock ...

Merck is planning layoffs in Pennsylvania as part of a multi-year plan to wind down operations at a manufacturing plant in the state. The pharma giant will cut 163 jobs at its Cherokee ...

NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...

Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor. In return for the ex-China rights to the drug, dubbed HRS-5346, Merck has ...

Just a few years after debuting its original logo, the Max streaming service, surprised users with an updated new logo and ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

Merck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 billion, the latest in a series of cross-border deals between Western ...